I Azaïs

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 899 citations · Full text

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

Cyrille Hulin, Thierry Façon, Philippe Rodon et al. · Journal of Clinical Oncology · 2009 · 380 citations

Optimal Duration of Antibiotic Therapy in Vertebral Osteomyelitis

F. Roblot, Jean‐Marc Besnier, L. Juhel et al. · Seminars in Arthritis and Rheumatism · 2007 · 172 citations

Optimal Duration, Antibiotics, Antibiotic Adjuvant +5

Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature

Jean‐Marie Berthelot, Michel De Bandt, Philippe Goupille et al. · Joint Bone Spine · 2008 · 116 citations

Maternal Cardiovascular Outcome, Medicine, Maternal Complication +9

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

Cyrille Hulin, Andrew R. Belch, Chaim Shustik et al. · Journal of Clinical Oncology · 2016 · 81 citations

Progression-free Survival, Immunology, Pharmacotherapy +20